Shiono, A., Kaira, K., Mouri, A., Yamaguchi, O., Hashimoto, K., Uchida, T., . . . Kagamu, H. (2019). Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients. Thorac Cancer.
Citación estilo ChicagoShiono, Ayako, et al. "Improved Efficacy of Ramucirumab Plus Docetaxel After Nivolumab Failure in Previously Treated Non‐small Cell Lung Cancer Patients." Thorac Cancer 2019.
Cita MLAShiono, Ayako, et al. "Improved Efficacy of Ramucirumab Plus Docetaxel After Nivolumab Failure in Previously Treated Non‐small Cell Lung Cancer Patients." Thorac Cancer 2019.
Precaución: Estas citas no son 100% exactas.